-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ORYTCxFyV1z3qg+54y0c1NjOEDtU60AJ2xbKh66T4Gp2Eez0uvEpCyZEVuU7zMfI b0nzoeV635NM4QUFBFMblg== 0001144204-09-001594.txt : 20090112 0001144204-09-001594.hdr.sgml : 20090112 20090112173107 ACCESSION NUMBER: 0001144204-09-001594 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090112 FILED AS OF DATE: 20090112 DATE AS OF CHANGE: 20090112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLETCHER MARK CENTRAL INDEX KEY: 0001229529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 09522463 BUSINESS ADDRESS: STREET 1: C/O GENEREX BIOTECHNOLOGY CORP STREET 2: 33 HARBOUR SQUARE CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQUARE CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J2G2 4 1 v136893_ex.xml X0303 4 2009-01-12 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001229529 FLETCHER MARK 33 HARBOUR SQUARE SUITE 202 TORONTO ONTARIO CANADA A1 M5J2G2 BRITISH COLUMBIA, CANADA 0 1 0 0 EVP & General Counsel Common Stock 2009-01-12 4 P 0 10159 .32 A 245177 D Common Stock 2009-01-12 4 P 0 2200 .33 A 247377 D /s/ Mark Fletcher 2009-01-12 -----END PRIVACY-ENHANCED MESSAGE-----